Recurrent myocardial infarction in a postpartum patient receiving bromocriptine.
Myocardial infarction in puerperium is infrequently reported. Spasm, coronary dissection, or atheromatous etiology has been described. Bromocriptine has been implicated in several previous case reports of myocardial infarction in the puerperium. Our case (including an inadvertent rechallenge) suggests such a relationship. Although generally regarded as "safe," possible serious cardiac effects of bromocriptine should be acknowledged.
Eickman
F M
FM
Spartanburg Regional Medical Center, South Carolina 29303.
D000328:Adult; D001971:Bromocriptine / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007774:Lactation / Q000187:drug effects; D009203:Myocardial Infarction / Q000139:chemically induced*; D011644:Puerperal Disorders / Q000139:chemically induced*; D012008:Recurrence
D001971:Bromocriptine